We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$968M
AUM Growth
+$854M
Cap. Flow
+$792M
Cap. Flow %
81.87%
Top 10 Hldgs %
57.56%
Holding
371
New
110
Increased
49
Reduced
126
Closed
30

Top Buys

Rank Stock Value
1
EQM
EQM Midstream Partners, LP
EQM
+$80.7M
2
ETP
Energy Transfer Partners, L.P.
ETP
+$75.4M
3
MPLX icon
MPLX
MPLX
+$75.1M
4
MPC icon
Marathon Petroleum
MPC
+$60.6M
5
WMB icon
Williams Companies
WMB
+$40.5M

Top Sells

Rank Stock Value
1
VPU
Vanguard Utilities ETF
VPU
+$1.7M
2
VDE icon
Vanguard Energy ETF
VDE
+$1.28M
3
INDA icon
iShares MSCI India ETF
INDA
+$1.24M
4
FNCL icon
Fidelity MSCI Financials Index ETF
FNCL
+$1.04M
5
INCY icon
Incyte
INCY
+$637K

Sector Composition

Rank Sector Weight
1 Energy 68.15%
2 Healthcare 6.98%
3 Utilities 1.17%
4 Financials 0.09%
5 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTA icon
101
Enanta Pharmaceuticals
ENTA
$376M
$603K 0.06%
7,052
+475
+7% +$47.6K
VSTM icon
102
Verastem
VSTM
$554M
$599K 0.06%
6,880
-5,052
-42% -$502K
RNAC icon
103
Cartesian Therapeutics
RNAC
$237M
$598K 0.06%
1,282
-941
-42% -$378K
CRBP icon
104
Corbus Pharmaceuticals
CRBP
$174M
$585K 0.06%
2,581
-1,849
-42% -$299K
ACHN
105
DELISTED
Achillion Pharmaceuticals
ACHN
$582K 0.06%
158,277
-113,149
-42% -$337K
PTCT icon
106
PTC Therapeutics
PTCT
$6.37B
$579K 0.06%
12,326
-8,814
-42% -$365K
INO icon
107
Inovio Pharmaceuticals
INO
$81.2M
$578K 0.06%
8,667
-6,197
-42% -$345K
ECYT
108
DELISTED
Endocyte, Inc. Common Stock
ECYT
$567K 0.06%
31,923
-23,422
-42% -$402K
HIFR
109
DELISTED
InfraREIT, Inc.
HIFR
$566K 0.06%
+26,779
New +$568K
DNLI icon
110
Denali Therapeutics
DNLI
$3.76B
$559K 0.06%
25,718
-18,899
-42% -$313K
FLIN icon
111
Franklin FTSE India ETF
FLIN
$2.71B
$558K 0.06%
+25,763
New +$594K
ONCE
112
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$554K 0.06%
10,162
+685
+7% +$46.8K
GTHX
113
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$552K 0.06%
10,561
-7,542
-42% -$411K
NVAX icon
114
Novavax
NVAX
$1.25B
$549K 0.06%
14,606
-10,442
-42% -$294K
RCKT icon
115
Rocket Pharmaceuticals
RCKT
$357M
$536K 0.06%
21,774
-15,976
-42% -$347K
DOVA
116
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$532K 0.06%
25,375
+1,738
+7% +$41.4K
KERX
117
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$527K 0.05%
155,009
+10,445
+7% +$37.7K
VNQ icon
118
Vanguard Real Estate ETF
VNQ
$39.9B
$513K 0.05%
6,358
-6,597
-51% -$543K
SGMO
119
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$511K 0.05%
30,135
-21,556
-42% -$328K
ADAP
120
DELISTED
Adaptimmune Therapeutics
ADAP
$510K 0.05%
37,603
-27,618
-42% -$290K
ADVM
121
DELISTED
Adverum Biotechnologies
ADVM
$502K 0.05%
8,300
-6,095
-42% -$342K
CLVS
122
DELISTED
Clovis Oncology, Inc.
CLVS
$502K 0.05%
17,101
+1,171
+7% +$45.3K
PTLA
123
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$502K 0.05%
18,861
+1,271
+7% +$41.5K
ESPR
124
DELISTED
Esperion Therapeutics
ESPR
$501K 0.05%
11,297
-8,187
-42% -$376K
PVLA
125
Palvella Therapeutics
PVLA
$2.03B
$498K 0.05%
1,112
-795
-42% -$345K
3 4
5
6 7

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q3 2018 Portfolio in Review

As of Q3 2018, Virtus ETF Advisers held 371 positions worth $968M, up 755% from $113M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Virtus ETF Advisers deployed $792M of net new capital in Q3 2018, opening 110 new positions and adding to 49 existing holdings. Its largest new stake was EQM Midstream Partners, LP: 1,479,454 shares worth $78.1M.

By sector, the portfolio is most concentrated in Energy at 68% of assets, up from 0.33% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was Vanguard Utilities ETF, an estimated $1.7M trimmed.

  • Virtus ETF Advisers's largest Q3 2018 buy was EQM Midstream Partners, LP: 1,479,454 shares worth $78.1M.
  • Virtus ETF Advisers added most to Marathon Petroleum in Q3 2018, an estimated $60.6M increase.
  • Virtus ETF Advisers's biggest Q3 2018 reduction was Vanguard Utilities ETF, cutting an estimated $1.7M.
  • Virtus ETF Advisers fully exited iShares MSCI India ETF in Q3 2018, selling an estimated $1.24M.
  • Virtus ETF Advisers's ten largest holdings make up 58% of its $968M portfolio in Q3 2018.
  • Virtus ETF Advisers opened 110 new positions and closed 30 in Q3 2018.
  • Virtus ETF Advisers's portfolio value rose 755% quarter-over-quarter to $968M.

Based on Virtus ETF Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.